Press Releases

• December 12, 2018
  

  U.S. Food and Drug Administration Awards Contract to Critical Path Institute for Kidney Transplant Database

  Patient-level data will inform the creation of drug development tools and speed development of new immunosuppressive treatments TUCSON, Ariz., December 12, 2018 — The U.S. Food and Drug Administration (FDA) has awarded a contract to Critical Path Institute (C-Path) in support of a new project to create a database of patient-level clinical trial data that...
• November 5, 2018
  

  Critical Path Institute Rebrands One of Its First Consortia to Highlight Focus on Alzheimer’s Disease

  Critical Path for Alzheimer’s Disease (CPAD) consortium’s refined, refocused mission centers on accelerating therapy development for AD and related forms of dementia TUCSON, Ariz., November 5, 2018 — The Critical Path Institute (C-Path) is pleased to announce that its Critical Path for Alzheimer’s Disease (CPAD) consortium has refined and refocused its mission in celebration of...
• November 1, 2018
  

  C-Path, CHDI and CDISC Announce Therapeutic Area User Guide for Huntington’s Disease

  TUCSON, Ariz., NEW YORK and AUSTIN, Texas, November 1, 2018 — The Huntington’s Disease Regulatory Science Consortium (HD-RSC), launched in March 2018 by the Critical Path Institute (C-Path) and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium (CDISC), announce the open availability of a newly developed Huntington’s Disease Therapeutic Area User Guide...
• October 25, 2018
  

  FNIH Biomarkers Consortium and Critical Path Institute Achieve the First Ever Qualification of a Clinical Safety Biomarker by the U.S. Food and Drug Administration

  Major Milestone will Improve Detection of Drug-Induced Acute Kidney Injury in Clinical Trials.     October 25, 2018 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) and the Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC) have received the first ever qualification of a clinical safety biomarker awarded by...
• September 25, 2018
  

  UA Colleges of Law and Pharmacy, Critical Path Institute, Launch Graduate Certificate Program in Regulatory Science

  Designed for graduate students and working professionals, the certificate program provides specialized training in navigating the path from research to bringing medical products to market.   TUCSON, Ariz., September 25, 2018 — The University of Arizona and the Critical Path Institute have launched a new online graduate certificate program designed to equip students and working...